Skeletal effects of combined bisphosphonates treatment and parathyroidectomy in osteoporotic patients with primary hyperparathyroidism.
Hun Jee ChoeBo Kyung KooKa Hee YiSung Hye KongJung Hee KimChan Soo ShinJee Won ChaiSang Wan KimPublished in: Journal of bone and mineral metabolism (2021)
There is no additional benefit of BMD in combination treatment with bisphosphonates and PTX over PTX alone in osteoporotic patients with PHPT. Combined bisphosphonate treatment might interfere with the increase in bone mass caused by PTX.